Psychotropic drugs in somatic disorders.
Current trends in the employment of psychotropic medication in somatic illness are considered, and some of the theoretical issues raised by this practice are explored. While much further clinical investigation is needed, a review is made of currently available knowledge regarding psychopharmacotherapy in specific clinical settings: pain, delirium, ischemic heart disease, gastrointestinal disorders, dermatological illness, and in renal, hepatic and pulmonary insufficiency.
D003327:Coronary Disease / Q000188:drug therapy; D003693:Delirium / Q000188:drug therapy; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy; D008107:Liver Diseases / Q000188:drug therapy; D008173:Lung Diseases, Obstructive / Q000188:drug therapy; D010146:Pain / Q000188:drug therapy; D011602:Psychophysiologic Disorders / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012871:Skin Diseases / Q000188:drug therapy
D011619:Psychotropic Drugs